Drug major Lupin has launched generic version of Wyeth's Pristiq tablets, an anti-depressant drug, in the American market.
Lupin's Desvenlafaxine Succinate extended-release tablets are generic version of Wyeth Pharmaceuticals' Pristiq tablets used in the treatment of major depressive disorder (MDD).
According to IMS MAT December 2016 data, Pristiq tablets had annual US sales of around USD 859.9 million.
Lupin shares were trading 0.01 per cent up at Rs 1,469.6 on the BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)